Artículos de revistas
Primary sequence determination of a Kunitz inhibitor isolated from Delonix regia seeds
Registro en:
Phytochemistry. Pergamon-elsevier Science Ltd, v. 57, n. 5, n. 625, n. 631, 2001.
0031-9422
WOS:000169481100002
10.1016/S0031-9422(01)00080-2
Autor
Pando, SC
Oliva, MLV
Sampaio, CAM
Di Ciero, L
Novello, JC
Marangoni, S
Institución
Resumen
A serine proteinase inhibitor was purified from Delonix regia seeds a Leguminosae tree of the Caesalpinioideae subfamily. The inhibitor named DrTI, inactivated trypsin and human plasma kallikrein with K-i values 2.19x10(-8) M and 5.25 nM, respectively. Its analysis by SDS-PAGE 10-20% showed that the inhibitor is a protein with a single polypeptide chain of M-r 22 h Da. The primary sequence of the inhibitor was determined by Edman degradation, thus indicating that it contained 185 amino acids and showed that it belongs to the Kunitz type family; however, its reactive site did not contain Arg or Lys at the putative reactive site (position 63, SbTI numbering) or it was displaced when compared to other Kunitz-type inhibitors. (C) 2001 Elsevier Science Ltd. All rights reserved. 57 5 625 631
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors
Reis J.; Cagide F.; Valencia M.E.; Teixeira J.; Bagetta D.; Pérez C.; Uriarte E.; Oliveira P.J.; Ortuso F.; Alcaro S.; Rodríguez-Franco M.I.; Borges F. (Elsevier Masson SAS, 2018) -
SGLT-2 inhibitors for people with type 2 diabetes.
Autor desconocido (Elsevier, 2019)Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ... -
Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway
Bengoetxea H.; Rico-Barrio I.; Ortuzar N.; Murueta-Goyena A.; Lafuente J.V. (Humana Press Inc., 2018)